GS1 is a Belgium-based organization established in 1974, operating within the software industry with a focus on supply chain management and product identification. The company has developed standards and solutions aimed at enhancing the integrity and safety of supply chains, particularly in the healthcare sector. Its published documents highlight the importance of serialization, which involves assigning unique identifiers to individual product units, thereby enabling tracking throughout the supply chain. This process is crucial in combating counterfeit medicines, especially in regions with limited regulatory oversight. GS1's initiatives, as evidenced by case studies, demonstrate its commitment to improving patient safety and regulatory readiness by encouraging companies to adopt serialization proactively. Additionally, GS1 is involved in sustainability research, as indicated by its publication on sustainability discovery projects, reflecting its broader engagement with environmental considerations in supply chain practices. With an employee size of 51-200 and reported revenue of approximately $59.9 million, GS1 continues to play a significant role in shaping standards for product identification and traceability.